Abbott, Alere Stalled Takeover Fight May Be Heard in JanuaryJef Feeley and Michelle Fay Cortez
Court’s former chief judge will serve as mediator if needed
Abbott proposed schedule for antitrust regulatory filings
Alere Inc.’s bid to force Abbott Laboratories to complete its stalled $5.8 billion takeover of the medical testing company could linger into January.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.